SBIR/STTR Research Award

Engineered Antibodies for Imaging Gene Expression

Award identifier d8723894dcb2af3228cfa5184e094b6292a7701deedfd61d77bfc97dc1fc8d87Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$97,776

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LEXRITE LABS
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Provided by Applicant): Observing the expression of transfected genes in a living system, with minimal disturbance, is important for the future development of gene therapy. We propose an approach that possesses many of the best features of recent advances in this area, but extends the power of imaging in new directions. The metallic elements possess a variety of useful physical properties that make them valuable as probes. These include radioactive emissions of photons for gamma or PET imaging, radioactive emissions of particles for therapy, paramagnetism for MRI contrast, luminescence for optical imaging, etc. Chemistry for making use of these properties in biomedical applications is fundamental to the further development of imaging instrumentation and technology. We will demonstrate the feasibility of imaging gene expression with metal chelates by engineering an antibody so that it is expressed as a cell-surface receptor for metal chelates, under the control of an inducible transcription unit. When expressed on the cell surface, this new receptor will capture labeled chelates and ultimately provide an image of the cluster of transformed cells that express the receptor. Phase 2 will focus on development of new products that apply this technology to a useful set of metallic elements and imaging techniques. PROPOSED COMMERCIAL APPLICATION: High-resolution imaging of gene expression in cancer cells is important to the future science and technology of cancer treatment. The molecular tools that we prepare will allow the physical properties of metallic elements to be employed in new ways. They will find uses in a variety of high-technology imaging applications, in both research and (ultimately) clinical applications.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.